30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Keith Katkin

Insider profile

Currently holds a position at Syndax Pharmaceuticals Inc

Performance

Overall performance
3.2

Performance over holding periods
3.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Keith Katkin's trades of Emergent BioSolutions Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-04 2026-04-30 PlS Planned sale
5,934 -46.1%
298.84
US$3,549,197
5,934 -46.1% 298.84 US$3,549,197
2026-04-30 2026-04-30 PrS Proposed sale
32,853
267.96
US$2,816,607
32,853 267.96 US$2,816,607
2025-05-28 2025-05-23 PlS Planned sale
2,164 -40.8%
324.56
US$838,839
2,164 -40.8% 324.56 US$838,839
2025-05-23 2025-05-23 PrS Proposed sale
7,844
6.30
US$49,409
7,844 6.30 US$49,409
2025-05-19 2025-05-19 B Purchase
10,000 +11.1%
9.11
US$91,120
10,000 +11.1% 9.11 US$91,120
2022-10-07 2022-10-06 PlS Planned sale
9,117 -22.2%
25.90
US$236,139
9,117 -22.2% 25.90 US$236,139
2022-10-07 2022-10-06 PlS Planned sale
20,782 -39.4%
25.90
US$538,273
20,782 -39.4% 25.90 US$538,273
2022-10-04 2022-10-04 PlS Planned sale
223 -0.7%
25.00
US$5,575
223 -0.7% 25.00 US$5,575
2022-10-04 2022-10-04 PlS Planned sale
137 -0.4%
25.00
US$3,425
137 -0.4% 25.00 US$3,425
2022-10-04 2022-10-03 PlS Planned sale
13 -0.0%
25.00
US$325
13 -0.0% 25.00 US$325
2022-10-04 2022-10-03 PlS Planned sale
167 -0.5%
25.00
US$4,175
167 -0.5% 25.00 US$4,175
2022-10-04 2022-09-30 PlS Planned sale
647 -2.0%
25.07
US$16,221
647 -2.0% 25.07 US$16,221
2022-10-04 2022-09-30 PlS Planned sale
2,914 -8.3%
25.07
US$73,056
2,914 -8.3% 25.07 US$73,056